Therapeutic applications of circadian rhythms for the cardiovascular system.
The cardiovascular system exhibits dramatic time-of-day dependent rhythms, for example the diurnal variation of heart rate, blood pressure, and timing of onset of adverse cardiovascular events such as heart attack and sudden cardiac death. Over the past decade, the circadian clock mechanism has emerged as a crucial factor regulating these daily fluctuations. Most recently, these studies have led to a growing clinical appreciation that targeting circadian biology offers a novel therapeutic approach toward cardiovascular (and other) diseases. Here we describe leading-edge therapeutic applications of circadian biology including (1) timing of therapy to maximize efficacy in treating heart disease (chronotherapy); (2) novel biomarkers discovered by testing for genomic, proteomic, metabolomic, or other factors at different times of day and night (chronobiomarkers); and (3) novel pharmacologic compounds that target the circadian mechanism with potential clinical applications (new chronobiology drugs). Cardiovascular disease remains a leading cause of death worldwide and new approaches in the management and treatment of heart disease are clearly warranted and can benefit patients clinically.
Cardiovascular Research Group, Department of Biomedical Sciences, University of Guelph Guelph, ON, Canada.
Elena V
EV
Tsimakouridze
Cardiovascular Research Group, Department of Biomedical Sciences, University of Guelph Guelph, ON, Canada.
Faisal J
FJ
Alibhai
Cardiovascular Research Group, Department of Biomedical Sciences, University of Guelph Guelph, ON, Canada.
Tami A
TA
Martino
biomarkers; cardiovascular disease; chronotherapy; circadian; diurnal